These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5558655)

  • 1. The tolbutamide Controversy: a personal perspective.
    Schwartz TB
    Ann Intern Med; 1971 Aug; 75(2):303-6. PubMed ID: 5558655
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolbutamide study raises blood pressures.
    Nature; 1970 Dec; 228(5278):1251-2. PubMed ID: 5536884
    [No Abstract]   [Full Text] [Related]  

  • 3. Comments on the UGDP study.
    Schöffling K
    Horm Metab Res; 1974; Suppl 4():188-91. PubMed ID: 4608018
    [No Abstract]   [Full Text] [Related]  

  • 4. A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP).
    Seltzer HS
    Diabetes; 1972 Sep; 21(9):976-9. PubMed ID: 5055722
    [No Abstract]   [Full Text] [Related]  

  • 5. The University Group Diabetes Program. A statistician looks at the mortality results.
    Schor S
    JAMA; 1971 Sep; 217(12):1671-5. PubMed ID: 4937385
    [No Abstract]   [Full Text] [Related]  

  • 6. The University Group Diabetes Program. A further statistical analysis of the mortality findings.
    Cornfield J
    JAMA; 1971 Sep; 217(12):1676-87. PubMed ID: 4937386
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
    Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
    JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
    [No Abstract]   [Full Text] [Related]  

  • 8. The UGDP--tolbutamide and mortality.
    Knowles HC
    Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
    [No Abstract]   [Full Text] [Related]  

  • 9. [The venture of University Group Diabetes Program (UGDP). Some personal reflexions. Tolbutamide and phenformin under accusation].
    Pirart J
    Nouv Presse Med; 1972 Jan; 1(5):325-8. PubMed ID: 5010448
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: Oral hypoglycemic drugs.
    Scoville AB
    J Tenn Med Assoc; 1975 Apr; 68(4):319-20. PubMed ID: 1117723
    [No Abstract]   [Full Text] [Related]  

  • 11. [Are oral antidiabetics ineffective-or even dangerous? The "University Group Diabetes Program" (UGDP) as basis for a controversial discussion on the therapy of diabetes in the aged].
    Teuscher A
    Schweiz Med Wochenschr; 1972 Jun; 102(24):848-55. PubMed ID: 5033623
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of tolbutamide and chloramphenicol in diabetic patients.
    Brunová E; Slabochová Z; Platilová H; Pavlik F; Grafnetterová J; Dvorácek K
    Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):7-12. PubMed ID: 838527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the use of sulphonylurea derivatives in the treatment of diabetes mellitus dangerous?
    Constam GR
    Diabetologia; 1971 Aug; 7(4):237-9. PubMed ID: 5093706
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of propranolol on the hypoglycemic action of insulin and tolbutamide in diabetic patients].
    Kowalski S; Wolański A
    Pol Arch Med Wewn; 1969; 42(1):55-61. PubMed ID: 5767511
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of tolbutamide in diabetes and pregnancy].
    Villanueva Gasca A; María García L; López Villegas J; Núñez E
    Ginecol Obstet Mex; 1975 Aug; 38(226):133-7. PubMed ID: 1175987
    [No Abstract]   [Full Text] [Related]  

  • 16. The UGDP controversy. Clinical trials versus clinical impressions.
    Prout TE; Knatterud GL; Meinert CL; Klimt CR
    Diabetes; 1972 Oct; 21(10):1035-40. PubMed ID: 4561330
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of diagnostic criteria on the mortality findings in the University Group Diabetic Programme study of diabetic therapy.
    Gray RH
    Med J Aust; 1973 Mar; 1(12):594-6. PubMed ID: 4573383
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immediate effect of short-lasting insulin administration on the action of tolbutamide in diabetic patients].
    Grabowska MJ
    Pol Tyg Lek; 1967 Jul; 22(28):1064-6. PubMed ID: 6061141
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypoglycaemia due to azapropazone-tolbutamide interaction.
    Waller DG; Waller D
    Br J Rheumatol; 1984 Feb; 23(1):24-5. PubMed ID: 6697069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unsettling UGDP controversy.
    Sackler AM
    JAMA; 1980 Apr; 243(14):1435-6. PubMed ID: 6987429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.